FDA Drug Application (205429) for DAPSONE by ALVOGEN

Back to FDA Applications sponsored by ALVOGEN

Application Number205429
Product Number001
FormTABLET;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDAPSONE
Active IngredientDAPSONE

Active IngredientCount
List of drugs with Active Ingredient DAPSONE2


Back to FDA Applications sponsored by ALVOGEN